NCT03311308 2025-05-06A Trial of Pembrolizumab and Metformin Versus Pembrolizumab Alone in Advanced MelanomaUniversity of PittsburghPhase 1 Recruiting30 enrolled
NCT04114136 2025-02-10Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor MalignanciesUniversity of PittsburghPhase 2 Recruiting72 enrolled
NCT01638676 2021-10-29A Phase I/II Trial of Vemurafenib and Metformin to Melanoma PatientsUniversity of LouisvillePhase 1/2 Recruiting55 enrolled